Lammer J, Beaufort F, Steiner H
Wien Klin Wochenschr. 1985 Sep 13;97(17):690-3.
Indirect mesentericoportography was performed in 36 patients after administration of prostaglandin E1 and immediately before contrast medium injection. The results were compared with the findings in a control group of 20 patients receiving tolazoline as vasodilator. On comparing prostaglandin E1 with tolazoline no significant improvement in contrast enhancement of the superior mesenteric vein was obtained. On the other hand, prostaglandin E1 seemed to produce less side effects than tolazoline.
对36例患者在给予前列腺素E1后且在注射造影剂之前进行了间接肠系膜门静脉造影。将结果与20例接受妥拉唑啉作为血管扩张剂的对照组患者的检查结果进行了比较。将前列腺素E1与妥拉唑啉进行比较时,肠系膜上静脉的造影增强未见显著改善。另一方面,前列腺素E1似乎比妥拉唑啉产生的副作用更少。